FDA recall D-1105-2023

TMC Acquisitions LLC dba Tailor Made Compounding · Class II · drug

Product

Semaglutide/Cyanocobalamin 2mg/0.4mg/mL, 1mLvials, Tailor Made Compounding.

Reason for recall

Lack of Assurance of Sterility

Distribution

Nationwide within the USA

Key facts

Status
Terminated
Initiation date
2023-08-15
Report date
2023-08-30
Termination date
2024-09-30
Voluntary/Mandated
Voluntary: Firm initiated
Location
Nicholasville, KY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1105-2023